Bolt Biotherapeutics (BOLT) Other Gross PP&E Adjustments (2020 - 2025)
Bolt Biotherapeutics (BOLT) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$10.6 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 6.53% to -$10.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.6 million through Dec 2025, up 6.53% year-over-year, with the annual reading at -$10.6 million for FY2025, 6.53% up from the prior year.
- Other Gross PP&E Adjustments hit -$10.6 million in Q4 2025 for Bolt Biotherapeutics, up from -$11.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $6.3 million in Q2 2021 to a low of -$17.5 million in Q3 2021.
- Historically, Other Gross PP&E Adjustments has averaged -$9.5 million across 5 years, with a median of -$11.1 million in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: crashed 360.44% in 2022 and later skyrocketed 33.04% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$16.0 million in 2021, then increased by 27.04% to -$11.7 million in 2022, then rose by 28.14% to -$8.4 million in 2023, then plummeted by 34.81% to -$11.3 million in 2024, then rose by 6.53% to -$10.6 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for BOLT at -$10.6 million in Q4 2025, -$11.2 million in Q3 2025, and -$12.0 million in Q2 2025.